You are viewing the site in preview mode

Skip to main content

Table 1 Details of subjects with pulmonary Mycobacterium avium complex disease and dosage of each drug

From: Serum concentrations of clarithromycin and rifampicin in pulmonary Mycobacterium avium complex disease: long-term changes due to drug interactions and their association with clinical outcomes

Subject Gender Age (years) Weight (kg) Species Dosage (mg/day)
CAM RFP EB
A female 68 58 M.avium 800 600 750
B male 70 64 M.avium 800 450 750
C female 68 43 M.avium 600 450 500
D female 64 42 M.avium 800 450 500
E female 50 51 M.intracellulare 800 450 750
F female 63 47 M.avium 800 450 750
G female 70 56 M.avium 800 600 750
H female 71 48 M.avium 800 450 750
I male 75 47 M.avium and M.intracellulare 800 450 750